Systemic administration of BM-MSCs gives rise to a recovery of pancreatic islets, enhances secretion of blood insulin, and corrects hyperglycemia, as reported by Jurewicz et al. [59] and Ezquer et al. [60]. This evidence concerns the gene INS and Hyperglycemia.